David W Gryska, a director of PDL BioPharma, recently acquired 71,023 shares of the company. The buys took place at $3.52 per share, on June 02, 2016. Gryska now owns 104,434 shares of the company. Gryska operates out of Incline Village, NV. Some additional info was provided as follows:
The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc. During the one-year vesting period, the grant recipient will have the right to vote the shares and receive any dividends and other distributions paid, except that dividends and other distributions will be accumulated and will vest and be paid, with interest, on the earlier of the same vesting conditions as the origin
al award or March 15th of the year following the payment of such dividend or distribution to all stockholders.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever PDL BioPharma makes a similar move, sign up!
Other recent filings from the company include the following:
Pdl Biopharma Terminates Interest In Pursuing Acquisition Of Neos - Feb. 20, 2018
Renaissance Technologies LLC just provided an update on share ownership of PDL BioPharma - Feb. 14, 2018
STATE STREET CORPORATION just provided an update on share ownership of PDL BioPharma - Feb. 14, 2018
The Vanguard Group just provided an update on share ownership of PDL BioPharma - Feb. 9, 2018
BlackRock, Inc. just provided an update on share ownership of PDL BioPharma - Jan. 23, 2018